Stock Detail
VANDA PHARMACEUTICALS INC
Biotechnology
VNDA @ Yahoo Finance | VNDA Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $5.30 | $5.36 | $-0.08 | -1.49% | 0.00 | $5.38 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $5.31 | $5.29 | 101,471 | 149.02M | 150,590 | -75.71 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 5.39 | 5.35 | 5.32 | 5.28 | 5.25 |
Stock Profile
Vanda Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of clinical-stage drug candidates for various central nervous system disorders. It offers iloperidone, a compound for the treatment of schizophrenia and bipolar disorder; and VEC-162, a compound for the treatment of sleep and mood disorders. The company also provides VSF-173, a compound for the treatment of excessive sleepiness. Vanda Pharmaceuticals was founded in 2002 and is headquartered in Rockville, Maryland.